Omicron: Number of vaccine breakthroughs in cancer patients on the rise, study finds
For cancer patients, COVID-19 poses a particular risk due to their often compromised immune systems. Now, a study shows that, due to Omicron, there is an increasing number of breakthrough infections in people with cancer, especially while they are undergoing cancer therapy.
Materials provided by Medical University of Vienna. Note: Content may be edited for style and length.
Source link aaaaa